APA (7th ed.) Citation

Mayer, L., Pandak, W. M., Melmed, G. Y., Hanauer, S. B., Johnson, K., Payne, D., . . . Fischkoff, S. A. (2013). Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study. Inflammatory bowel diseases, 19(4), 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df

Chicago Style (17th ed.) Citation

Mayer, Lloyd, William M. Pandak, Gil Y. Melmed, Stephen B. Hanauer, Kristine Johnson, Denise Payne, Herbert Faleck, Robert J. Hariri, and Steven A. Fischkoff. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases 19, no. 4 (2013): 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df.

MLA (9th ed.) Citation

Mayer, Lloyd, et al. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases, vol. 19, no. 4, 2013, pp. 754-760, https://doi.org/10.1097/MIB.0b013e31827f27df.